Is IVF in Thailand Suitable for Advanced Maternal Age? Interpreting the Real Relationship Between Age and Success Rate
AI Summary
⚕️ AI Summary · Whether IVF in Thailand is suitable for advanced maternal age requires a comprehensive assessment based on specific age and ovarian reserve. The live birth rate for women under 38 in Thailand is approximately 45%–55%; for ages 38–40, it drops to 30%–40%; for ages 40–42, it is about 15%–25%; for women over 43, the live birth rate is less than 10%. Thailand offers third-generation IVF PGT‑A screening for older women, which can reduce the risk of miscarriage caused by embryonic chromosomal abnormalities, but it cannot reverse the fundamental impact of age on egg quality. For older women with AMH below 1.0 ng/mL and fewer than 5 antral follicles, the success rate of IVF in Thailand is also limited, and blind pursuit is not recommended. Before making a decision, a basic fertility assessment should be completed, including AMH, FSH, antral follicle count, and male semen analysis.
Is IVF in Thailand Suitable for Advanced Maternal Age? How Does Medicine Determine "Suitability"?
Whether IVF in Thailand is suitable for women of advanced maternal age is not judged by "whether it can be done" but by "whether the value and risk ratio are acceptable." Core evaluation indicators include: age, AMH, FSH, antral follicle count, previous pregnancy history, and control of underlying diseases. Thailand has relatively open policies for advanced maternal age in assisted reproduction, and third-generation IVF PGT‑A screening is widely available. However, the biological limitations of age on egg quality cannot be reversed in any country.
From a reproductive medicine perspective, "advanced maternal age" has clear clinical stratification: over 35 is considered advanced maternal age, over 38 is significantly advanced, and over 40 sees a stepwise decline in live birth rates. The key to determining suitability for IVF in Thailand lies in the physiological age of the ovaries rather than chronological age—some 38-year-old women may have ovarian function equivalent to a 45-year-old, while some 42-year-old women may still have sufficient ovarian reserve to support effective ovarian stimulation.
Three prerequisites for determining suitability:
- AMH ≥ 1.0 ng/mL and antral follicle count ≥ 5
- No uncontrolled thyroid disease, autoimmune disease, or uterine organic pathology
- Male semen analysis results support ICSI or conventional fertilization
Age and Ovarian Reserve: The Core Variables Determining IVF Success Rate
The number of oocytes in women is fixed at birth, approximately 1–2 million, decreasing to 300,000–400,000 by puberty, with accelerated depletion after age 35. Egg quality also declines with age, mainly manifested by an increased rate of chromosomal aneuploidy—about 30% under 35, 60% at age 40, and over 80% after 43. This is the fundamental reason for the decline in IVF success rates with advanced age and is not directly related to ovarian stimulation protocols or laboratory techniques.
Interpreting Test Indicators: How to Assess Your Ovarian Reserve
The following four tests are essential for older women to complete before going to Thailand. The results directly influence the judgment of "suitability":
| Indicator | Normal Range | Borderline Value | Common Situation in Advanced Age |
|---|---|---|---|
| AMH | 1.5–4.0 ng/mL | 0.5–1.0 ng/mL | Decreases with age; often below 1.0 after 40 |
| FSH (Day 2–3 of menstrual cycle) | <10 IU/L | 10–15 IU/L | Elevated FSH indicates decreased ovarian response |
| Antral Follicle Count (AFC) | 8–15 | 5–7 | <5 indicates significantly diminished ovarian reserve |
| LH/FSH Ratio | 0.5–1.5 | >2.0 | Polycystic ovary syndrome needs to be ruled out |
For older women with AMH below 0.5 ng/mL or fewer than 3 antral follicles, the success rate of IVF in Thailand is extremely low. Doctors usually recommend directly considering egg donation instead of using their own eggs.
Reference IVF Success Rates in Thailand by Age Group
The following data are based on publicly available global assisted reproduction industry data (comprehensive ranges from SART, ESHRE, and domestic reproductive center annual reports) for decision-making reference:
| Age | Live Birth Rate per Egg Retrieval Cycle | Live Birth Rate per Transfer Cycle | Live Birth Rate After PGT‑A |
|---|---|---|---|
| Under 35 | 45%–55% | 50%–60% | 55%–65% |
| 35–37 | 35%–45% | 40%–50% | 45%–55% |
| 38–40 | 20%–30% | 25%–35% | 30%–40% |
| 40–42 | 10%–20% | 15%–25% | 20%–30% |
| 42–44 | 5%–10% | 8%–15% | 10%–18% |
| Over 44 | <5% | <8% | <10% |
Explanation of the table: PGT‑A screening can exclude chromosomally aneuploid embryos and reduce miscarriage rates, but it cannot increase the number of usable embryos. The main bottleneck limiting the effectiveness of PGT‑A for older women is the low number of retrieved eggs and low blastocyst formation rate.
Thailand's Policies on IVF for Advanced Maternal Age and Third-Generation IVF PGT‑A
Thailand is one of the most open countries in Asia regarding IVF policies for advanced maternal age. The law allows chromosomal screening (PGT‑A) of embryos and has no strict upper age limit for women. However, medical institutions conduct individualized assessments based on medical indications. This contrasts with the strict indications for third-generation IVF in China, where it is required for chromosomal abnormalities, recurrent miscarriage, or recurrent implantation failure. In Thailand, PGT‑A can be directly used in the field of IVF for advanced maternal age.
IVF hospitals in Thailand commonly use vitrification technology, supporting frozen embryo transfers and cycle accumulation. For older women, doctors often recommend a "cumulative cycle" strategy—multiple ovarian stimulation cycles to accumulate embryos, followed by unified screening and transfer.
Timeline for IVF in Thailand (Standard Path for Advanced Age):
- Weeks 1–2: Complete basic tests at home (AMH, hormones, semen analysis, infectious disease screening, chromosome karyotype)
- Weeks 3–4: Schedule an appointment with a Thai clinic, remote consultation, determine ovarian stimulation protocol
- Weeks 5–6: Travel to Thailand on day 2 of menstruation, start ovarian stimulation (average 9–12 days)
- Week 7: Egg retrieval surgery (under anesthesia, about 20 minutes)
- Weeks 8–9: Embryo culture + PGT‑A screening (waiting period of 7–10 days)
- Weeks 10–11: Frozen embryo transfer (hormone replacement cycle or natural cycle)
- 12–14 days after transfer: Blood test to confirm pregnancy
When is it Suitable to Go to Thailand for IVF?
Based on clinical experience, the benefits of going to Thailand for IVF are relatively clear for older women in the following situations:
- AMH ≥ 1.0 ng/mL, antral follicle count ≥ 5: Ovarian reserve is acceptable, providing a basis for obtaining sufficient eggs
- Previous history of confirmed embryonic chromosomal abnormalities: PGT‑A can significantly reduce the risk of another miscarriage
- Recurrent implantation failure (≥2 times): PGT‑A has clear value when embryo factors need to be ruled out
- Need for egg freezing or embryo accumulation: Thailand has mature vitrification technology, supporting unified transfer after multiple ovarian stimulation cycles
- Do not meet the indications for third-generation IVF in China: Thailand has more relaxed indications for PGT‑A
When is it Not Suitable to Go to Thailand for IVF?
In the following situations, blindly choosing IVF in Thailand is not recommended, or other options should be considered first:
- AMH below 0.5 ng/mL and fewer than 3 antral follicles: Extremely low egg yield, almost no usable embryos after PGT‑A
- Age over 45 and AMH undetectable: Live birth rate with own eggs is less than 1%; egg donation should be considered
- Uncontrolled uterine organic diseases: Such as intrauterine adhesions, endometrial polyps, submucosal fibroids; surgery is needed first
- Severe underlying diseases: Uncontrolled hypertension, diabetes, thyroid disease; pregnancy risk is high
- Carriers of chromosomal structural abnormalities: Genetic counseling is needed first to assess the feasibility of PGT‑SR or PGT‑M
⚠️ Most Common Pitfall: Some older women may have acceptable AMH levels but significantly decreased egg quality. After PGT‑A, all embryos could be aneuploid. It is recommended to complete a "diagnostic ovarian stimulation" cycle at home or at least a combined assessment of AMH + antral follicle count + FSH before traveling to Thailand to avoid going abroad blindly and ending up with no embryos available.
Easily Overlooked Details
For older women going to Thailand for IVF, the following details are often overlooked but have a substantial impact on the outcome:
- Male examination is equally important: Increased sperm DNA fragmentation rate in older men can affect embryo development potential; semen analysis and DFI testing should be completed simultaneously
- Passport must be valid for more than 6 months: An IVF cycle in Thailand usually requires 1–2 trips; an expired passport will affect the schedule
- Chromosome testing needs to be done 1 month in advance: Peripheral blood chromosome karyotype analysis takes 2–4 weeks to produce results; it is recommended to complete it at home in advance
- Basic conditioning cannot replace medical treatment: Supplements like Coenzyme Q10 and DHEA have limited evidence in the older population and cannot replace formal ovarian stimulation treatment
- Hysteroscopy should be performed before frozen embryo transfer: The incidence of endometrial polyps and adhesions increases in older women; transferring without treatment will reduce implantation rates
Frequently Asked Questions
Q: Can I still go to Thailand for IVF with low AMH?
A: When AMH is below 0.5 ng/mL, the live birth rate for IVF in Thailand drops significantly. Suitability depends on whether you accept the "cumulative cycle" strategy—multiple ovarian stimulation cycles to accumulate embryos for unified screening and transfer. If AMH is undetectable, it is recommended to directly evaluate egg donation options.
Q: What preparations are needed for advanced maternal age IVF in Thailand?
A: Basic fertility assessment (AMH, FSH, antral follicle count, semen analysis), chromosome karyotype, infectious disease screening (Hepatitis B, Hepatitis C, Syphilis, HIV), passport (valid for more than 6 months), visa (medical visa or tourist visa), and previous medical records. It is recommended to complete tests 1–2 months in advance.
Q: How long does IVF in Thailand take?
A: A single cycle takes about 2–3 months (including ovarian stimulation, egg retrieval, PGT‑A, frozen embryo transfer). If using a cumulative cycle strategy, the total time may extend to 4–6 months. It is recommended to reserve at least a 3-month time window.
Q: What are the risks of IVF in Thailand for advanced maternal age?
A: Main risks include: low number of eggs retrieved or empty follicles during ovarian stimulation, all embryos being aneuploid with no embryos available for transfer, abnormal PGT‑A results, implantation failure or miscarriage after transfer, ovarian hyperstimulation syndrome (lower incidence in older women but still possible), and high cost of handling medical disputes abroad.
Q: How to determine which hospital in Thailand is suitable for advanced maternal age?
A: Focus on three core indicators: ① Whether the laboratory has third-generation IVF PGT‑A qualifications; ② Whether there are specialized ovarian stimulation protocols for advanced age (such as PPOS protocol, mild stimulation protocol); ③ Whether the embryologists are experienced (older eggs require high operational skills). It is recommended to directly ask the hospital for live birth rate data stratified by age.
Doctor's Advice
From a reproductive doctor's perspective, older women should complete the following three-step evaluation before going to Thailand for IVF:
- Complete a full fertility assessment at home: Including AMH, hormone panel on day 2–3 of menstruation, antral follicle count, male semen analysis + DFI, and chromosome karyotype for both partners. These test results determine the basic judgment of "suitability."
- Have a remote consultation with a Thai doctor: Request a personalized ovarian stimulation protocol and estimated number of eggs retrieved, and clarify the expected number of embryos after PGT‑A. If the estimated number of usable embryos is 0–1, decide carefully.
- Assess economic and time costs: The total cost of IVF in Thailand is about 80,000–150,000 RMB (including medical, airfare, accommodation). For advanced age cycles, multiple trips to Thailand may be needed, potentially doubling the total cost. If the budget is limited, tertiary reproductive centers in China can also provide standardized assisted reproduction services.
The final judgment of suitability is not about "whether Thailand can do it," but "whether your biological ovarian age still has a chance." If AMH ≥ 1.0, antral follicle count ≥ 5, and no underlying diseases, IVF in Thailand is one of the reasonable options. If ovarian reserve is severely diminished, the live birth rate with your own eggs is extremely limited regardless of the country. In this case, exploring egg donation or adoption may be a more practical next step.
📋 Suggestions for Next Steps: If you decide to proceed with an IVF evaluation in Thailand, it is recommended to first complete the following tests at a tertiary reproductive center in China (can be done within 1 week): AMH + hormone panel on day 2 of menstruation + vaginal ultrasound antral follicle count + semen analysis. After obtaining the results, decide whether to start the Thailand process to avoid going abroad blindly and wasting time due to unmet basic conditions.
